Osteoarthritic human chondrocytes proliferate in 3D co‐culture with mesenchymal stem cells in suspension bioreactors |
| |
| Authors: | Madiha Khurshid Aillette Mulet‐Sierra Arindom Sen |
| |
| Affiliation: | 1. Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Canada;2. McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Canada;3. Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada;4. McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, CanadaAdetola Adesida and Arindom Sen are equally contributing senior authors. |
| |
| Abstract: | Osteoarthritis (OA) is a painful disease, characterized by progressive surface erosion of articular cartilage. The use of human articular chondrocytes (hACs) sourced from OA patients has been proposed as a potential therapy for cartilage repair, but this approach is limited by the lack of scalable methods to produce clinically relevant quantities of cartilage‐generating cells. Previous studies in static culture have shown that hACs co‐cultured with human mesenchymal stem cells (hMSCs) as 3D pellets can upregulate proliferation and generate neocartilage with enhanced functional matrix formation relative to that produced from either cell type alone. However, because static culture flasks are not readily amenable to scale up, scalable suspension bioreactors were investigated to determine if they could support the co‐culture of hMSCs and OA hACs under serum‐free conditions to facilitate clinical translation of this approach. When hACs and hMSCs (1:3 ratio) were inoculated at 20,000 cells/ml into 125‐ml suspension bioreactors and fed weekly, they spontaneously formed 3D aggregates and proliferated, resulting in a 4.75‐fold increase over 16 days. Whereas the apparent growth rate was lower than that achieved during co‐culture as a 2D monolayer in static culture flasks, bioreactor co‐culture as 3D aggregates resulted in a significantly lower collagen I to II mRNA expression ratio and more than double the glycosaminoglycan/DNA content (5.8 vs. 2.5 μg/μg). The proliferation of hMSCs and hACs as 3D aggregates in serum‐free suspension culture demonstrates that scalable bioreactors represent an accessible platform capable of supporting the generation of clinical quantities of cells for use in cell‐based cartilage repair. |
| |
| Keywords: | cartilage tissue engineering cell aggregate co‐culture chondrocytes mesenchymal stem cells scale‐up suspension bioreactors |
|
|
